Anxiety medication isn’t inherently bad for you, but every class of drug used to treat anxiety carries real trade-offs that depend on the type of medication, how long you take it, and your individual health profile. For most people with moderate to severe anxiety, the risks of leaving it untreated, including elevated blood pressure, higher rates of cardiovascular disease, worsening chronic pain, and a slide toward depression, are greater than the risks of well-managed medication. That said, some anxiety drugs carry significant concerns around dependency, withdrawal, and side effects that are worth understanding before you start or continue treatment.
SSRIs: The Most Commonly Prescribed Option
The medications most psychiatrists reach for first are SSRIs, a class of antidepressants that also work well for anxiety. They carry no risk of physical dependency in the way that more sedating drugs do, and their side effect profile is generally milder. That’s the good news.
The most common downside is sexual dysfunction. Estimates range from 30% to 40% of people on these medications experiencing some form of it, though the number climbs when patients are asked directly rather than left to bring it up themselves. One study found 41% reported sexual side effects when specifically questioned, compared to just 6% who mentioned it on their own. Other common side effects include nausea, weight changes, and drowsiness, particularly in the first few weeks.
There’s also an important safety note for younger users. The FDA requires a boxed warning on all antidepressants stating they can increase suicidal thinking and behavior in children and adolescents. A combined analysis of over 4,400 patients across 24 trials found the risk was about 4% on medication versus 2% on placebo. This risk is highest during the first few months of treatment or when doses change, which is why close monitoring matters during that window. This doesn’t mean these medications are off-limits for young people, but it does mean the early weeks require extra attention from families and prescribers.
Benzodiazepines: Fast Relief, Real Risks
Benzodiazepines work quickly, often within 30 minutes, which makes them appealing during acute panic or severe anxiety episodes. But they come with a steep cost if used regularly. These drugs lose effectiveness over time, meaning you need higher doses to get the same relief. That pattern is the classic setup for physical dependency.
The cognitive effects are well documented. A review of 68 placebo-controlled trials found that benzodiazepines consistently caused both memory-related and broader cognitive impairment, with stronger effects in adults over 65. Regular use is linked to reduced processing speed, impaired visual learning, and problems with concentration and attention. For older adults, the risks compound further: increased fall risk, confusion, and delirium.
Benzodiazepines also interact dangerously with alcohol and opioids. Alcohol is involved in roughly 1 in 5 benzodiazepine-related overdose deaths each year. The two substances amplify each other’s sedating effects because they act on overlapping brain pathways, and alcohol actually slows the body’s ability to clear certain benzodiazepines from the bloodstream, pushing drug levels higher than expected.
Stopping Medication Can Be Harder Than Expected
One of the most under-discussed risks of anxiety medication isn’t what happens while you take it. It’s what happens when you stop. About 56% of people discontinuing an SSRI experience withdrawal symptoms, which can include dizziness, “brain zaps” (a sensation like brief electrical jolts), flu-like feelings, nausea, irritability, sleep disruption, and a rebound of anxiety that can be difficult to distinguish from relapse.
The timing helps tell the difference: withdrawal typically starts within days of stopping or reducing a dose, while a genuine relapse of anxiety or depression takes weeks to months to develop. Physical symptoms like brain zaps or muscle pain also point toward withdrawal rather than a return of the original condition.
Safe tapering is slow. Current guidelines from NICE and the Royal College of Psychiatrists recommend reducing doses proportionally, cutting by about 25% at a time, over months or even years depending on how long you’ve been on the medication. Drugs with shorter half-lives require an even longer taper. Abruptly stopping or skipping doses (except with one specific longer-acting SSRI) creates sharp swings in drug levels that make withdrawal worse. If you experience significant symptoms during a taper, the recommended approach is smaller reductions, say 10% instead of 20%, with more time between each step.
SSRIs During Pregnancy
If you’re pregnant or planning to become pregnant, anxiety medication raises a different set of questions. The overall clinical consensus is that SSRIs are safe and well tolerated during pregnancy, and that untreated maternal anxiety carries its own risks for both mother and baby. But there are specific things to be aware of.
Up to 30% of newborns exposed to SSRIs in the third trimester develop what’s called poor neonatal adaptation syndrome: symptoms like jitteriness, mild breathing difficulty, and tremors that typically resolve within days to two weeks with basic comfort measures like swaddling and skin-to-skin contact. The risk of more serious complications, like a specific type of newborn lung condition, is about 3 per 1,000 live births. Some individual SSRIs have been linked to specific birth defects in certain studies, but the absolute risk remains low when an association has been found at all. No special monitoring is recommended for children who were exposed in the womb.
The Risk of Not Treating Anxiety
Any honest look at whether anxiety medication is “bad for you” has to weigh it against what chronic, untreated anxiety does to the body. Persistent anxiety is associated with elevated cardiovascular disease risk, higher blood pressure, and amplified pain perception. It also tends to worsen over time. Untreated anxiety frequently progresses to depression.
There’s also a behavioral cost. People with unmanaged anxiety are more likely to self-medicate with alcohol, tobacco, cannabis, or pain medications, all of which carry their own health risks and can create dependency problems that are at least as serious as anything a prescribed medication might cause. When alcohol is combined with anxiety or depression, it can reduce the effectiveness of treatment, lower adherence, and increase impulsivity, which raises suicide risk.
Matching the Medication to the Risk
Not all anxiety medications carry the same risks, and the right choice depends on your situation. SSRIs are the standard first-line treatment because they address anxiety effectively without dependency risk, though they take several weeks to reach full effect and can be difficult to stop. Benzodiazepines are useful for short-term or as-needed use but become problematic with daily, long-term use. Beta-blockers are sometimes prescribed for physical symptoms of anxiety like rapid heartbeat and trembling, and they don’t cause dependency, but there’s limited clinical evidence supporting their use for anxiety, and they carry their own safety concerns in overdose or when combined with antidepressants.
Therapy, particularly cognitive behavioral therapy, is effective for anxiety on its own or alongside medication, and for mild to moderate anxiety it may be sufficient without any drugs at all. For many people, the most practical approach is medication to bring symptoms to a manageable level, combined with therapy to build longer-term coping strategies, with a plan to eventually taper off the medication under guidance.